Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficary and Safety of Luspatercept for Treatment of Anaemia in Transfusion-dependent β-thalassaemia in Southwest China

NCT06164821 is registered in ClinicalTrials.gov with Hematology department of the 920th hospital as lead sponsor.

NCT NCT06164821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06164821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficary and Safety of Luspatercept for Treatment of Anaemia in Transfusion-dependent β-thalassaemia in Southwest China
Lead sponsor
Hematology department of the 920th hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2024
Completion date
November 30, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug